Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
02/2003
02/06/2003WO2003009867A1 Use of biologically active hiv-1 tat, fragments or derivates thereof, to target and/or to activate antigen-presenting cells, and/or to deliver cargo molecules for preventive or therapeutic vaccination and/or to treat other diseases
02/06/2003WO2003009866A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003WO2003009847A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003WO2003009845A1 Substituted urea neuropeptide y y5 receptor antagonists
02/06/2003WO2003009843A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria
02/06/2003WO2003009842A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003WO2003009841A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
02/06/2003WO2003009839A1 Benzofuranes and their use in the treatment of atrial fibrillation
02/06/2003WO2003009837A2 Treatment of vascular events in diabetics using lipid-modifying compositions
02/06/2003WO2003009828A1 Modifying the fatty acid composition of cell membranes of organs and tissues
02/06/2003WO2003009815A2 Compositions and methods for modulating blood-brain barrier transport
02/06/2003WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003WO2003009805A2 Analgesic methods using endothelin receptor ligands
02/06/2003WO2003009803A2 Method of improving cognitive function
02/06/2003WO2003009779A2 Delivery of therapeutic capable agents
02/06/2003WO2003009778A2 Methods and devices for delivery of therapeutic capable agents with variable release profile
02/06/2003WO2003009777A2 Delivery of therapeutic capable agents
02/06/2003WO2003000256A9 Substituted oxazolidinones for combinational therapy
02/06/2003WO2002095034A3 A retinoic acid metabolizing cytochrome p450
02/06/2003WO2002093177A3 Assays for identifying modulators of rhomboid polypeptides
02/06/2003WO2002089828A3 Interferons in the treatment of ischemia
02/06/2003WO2002087556A3 Probucol monoesters and their use to increase plasma hdl cholesterol levels and improve hdl functionality
02/06/2003WO2002079146A3 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
02/06/2003WO2002078605A3 Premixed amiodarone parenteral solution and method for making the same
02/06/2003WO2002067851A3 Method for treating fibrotic diseases or other indications iiic
02/06/2003WO2002064586A3 Heterocyclic inhibitors of erk2 and uses thereof
02/06/2003WO2002063005A3 Lipid-associated molecules
02/06/2003WO2002061110A3 Nucleic acid derivatives
02/06/2003WO2002059112A3 Pyrazole compounds useful as protein kinase inhibitors
02/06/2003WO2002048134A3 Di-substituted aminomethyl chroman derivative beta-3 adrenoreceptor agonists
02/06/2003WO2002046172A3 Substituted 1, 3, 5-triazines and pyrimidines as abca-1 elevating compounds against coronary artery disease or atherosclerosis
02/06/2003WO2002046141A3 Coumpounds of the formula r1-x-y-z-nr2r3 as abca-1 elevating agents against coronary artery disease or atherosclerosis
02/06/2003WO2002039953A3 Texaphyrin coordination compounds and uses thereof
02/06/2003WO2002030937A3 Labeled resiniferatoxin derivatives for use in vanilloid receptor binding assay
02/06/2003WO2002020722A3 Methods and compositions for in vitro targeting
02/06/2003WO2002019963A3 Synthetic erythropoiesis stimulating proteins
02/06/2003WO2002016965A3 Radioactive emission detector
02/06/2003WO2002010217A9 Endothelial cell expression patterns
02/06/2003WO2002010137A9 Indazole derivatives as jnk inhibitors
02/06/2003WO2002002645A8 COLD WATER SOLUBLE β-GLUCAN PRODUCT AND PROCESS FOR PREPARING THE SAME
02/06/2003WO2002002095A3 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
02/06/2003WO2001064874A9 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis
02/06/2003WO2001047946A3 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR
02/06/2003US20030028923 Nucleotide sequences coding enzymatic polypeptide for use in the generation of disease resistant plants
02/06/2003US20030028077 Cardiac disease treatment and device
02/06/2003US20030028038 Semi-synthetic taxanes with antitumor and antiangiogenetic activities
02/06/2003US20030028018 Treating diseases characterized by activity of vascular endothelial growth factor receptor tyrosine kinases such as cancer
02/06/2003US20030028008 Nucleotide sequences coding polypeptide for use in the treatment of urogenital, tumor, antherosclerotic and kidney disorders
02/06/2003US20030028004 68730 and 69112, protein kinase molecules and uses therefor
02/06/2003US20030027999 143 human secreted proteins
02/06/2003US20030027983 Transport protein for use in the treatment of blood, hypertensive and epileptic disorders
02/06/2003US20030027863 Such as restenosis and atherosclerosis.
02/06/2003US20030027859 3-aryl-2-hydroxypropionic acid derivative I
02/06/2003US20030027852 Substituted pyrrolidine-2,3,4-trione 3-oxime deerivatives which are active as NMDA receptor antagonists
02/06/2003US20030027840 Estrogen receptor modulators
02/06/2003US20030027836 Arylalkoxy-substituted tetrahydroisoquinoline-3-carboxylic acids or esters
02/06/2003US20030027831 Arylpiperzine derivatives are useful for treatment of anxiety, depression, hypertension, cognitive disorders, sexual dysfunction, brain trauma, memory loss, eating disorders, obesity, substance abuse, and obsessive-compulsive diseases
02/06/2003US20030027829 Potassium channel inhibitors
02/06/2003US20030027821 Administering 2-oxy substituted benzoxazin-5-one derivative to a human or animal for the prevention or treatment of obesity or an obesity related disorder
02/06/2003US20030027820 Method for treating fibrotic diseases or other indications V
02/06/2003US20030027814 Bis(5-aryl-2-pyridyl) compound having excellent immunoglobulin (IgE) antibody production inhibiting activity, useful for the prevention or treatment of allergic immune diseases
02/06/2003US20030027812 Useful for treating or preventing a disorder or condition selected from hypertension, depression, anxiety, phobias, post trauma stress, sexual disfunction, eating disorder, obesity, Alzheimer's disease, Parkinson's disease etc.
02/06/2003US20030027807 Vitronectin receptor antagonists, their preparation and their use
02/06/2003US20030027804 Administering to the mammal a menopause disorder effective amount of an orally deliverable pharmaceutically- acceptable sex hormone binding globulin synthesis inhibiting agent, and at least one of a non-orally deliverable steroids
02/06/2003US20030027794 N-heterocyclic derivatives as NOS inhibitors
02/06/2003US20030027759 Method of using PON-1 to decrease atheroma formation
02/06/2003US20030027749 For use in therapy, and diagnostic assays
02/06/2003US20030027304 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030027299 Biochemical conjugate for use in the treatment or prevention of stroke, heart defect, veinous thrombosis, sepsis and embolism
02/06/2003US20030027297 19 human secreted proteins
02/06/2003US20030027230 Detection of antiproliferative agents for treatment of ovarian cancer; obtain cells, incubate with modulator, monitor cells for reduction in cancer activity, reduction in cancer activity indicates antiproliferative agents
02/06/2003US20030027211 Fetuin-MGP-mineral complex in serum
02/06/2003US20030027188 SLC7s as modifiers of the p53 pathway and methods of use
02/06/2003US20030027164 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
02/06/2003US20030027158 Novel nucleic acid sequences encoding human breast tumor-associated protein 47-like polypeptides
02/06/2003US20030026862 (+)-Cycloolivil as antioxidant obtained from a new natural source namely stereospermum personatum
02/06/2003US20030026799 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor
02/06/2003US20030026796 Method for treating a subject suffering from conditions associated with an extracellular zinc sphingomyelinase
02/06/2003US20030026793 Hypoxia inducing factors and uses thereof for inducing angiogenesis and improving muscular functions
02/06/2003US20030026730 Apparatus having a defoamer-coated surface and use of a defoamer-containing surface
02/06/2003CA2857312A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using deoxyhypusine synthase (dhs)
02/06/2003CA2455602A1 Protein kinase inhibitors comprising atp mimetics conjugated to peptides or peptidomimetics
02/06/2003CA2454822A1 Nucleic acids, polypeptides, and methods for modulating apoptosis using apoptosis-specific eif-5a
02/06/2003CA2454803A1 Probiotic bifidobacterium strains
02/06/2003CA2454791A1 Antisense modulation of c-reactive protein expression
02/06/2003CA2454774A1 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
02/06/2003CA2454681A1 Medicament inhibiting sodium/calcium exchange system
02/06/2003CA2454562A1 Method of improving cognitive function
02/06/2003CA2454150A1 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same
02/06/2003CA2453919A1 8-methoxy-(1,2,4)triazolo(1,5-a)pyridine derivatives and their use as adenosine receptor ligands
02/06/2003CA2453894A1 Antisense modulation of hormone-sensitive lipase expression
02/06/2003CA2453653A1 Gmg-2 polynucleotides and polypeptides and uses thereof
02/06/2003CA2453587A1 Benzofuranes and their use in the treatment of atrial fibrillation
02/06/2003CA2453561A1 Use of the disintegrin domain of an adamalysin as anti-angiogenic, anti-invasive and anti-metastatic agent
02/06/2003CA2452328A1 Substituted piperidines as modulators of the melanocortin receptor
02/06/2003CA2452259A1 Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
02/06/2003CA2452256A1 Methods of inducing differentiation of stem cells
02/06/2003CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
02/06/2003CA2450073A1 Compositions and methods for modulating blood-brain barrier transport
02/06/2003CA2399583A1 Novel solvate and crystalline forms of lercanidipine hydrochloride
1 ... 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 1057 1058 1059 1060 1061 1062 1063 1064 1065 ... 1595